D

DermAssociates | Rockville, MD

Research site

(Unclaimed)

Location

15245 Shady Grove Road Suite 480, Rockville, Maryland, United States of America

Site insights

Top conditions

Top treatments

Risankizumab

Ruxolitinib

PF-04965842

Difamilast

VP-315

PF04965842

Upadacitinib

ABT-494

Dupilumab

Deucravacitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 18 total trials

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (EMBARQ-CSU1)

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urtic...

Active, not recruiting

Chronic Spontaneous Urticaria

Biological: barzolvolimab

Biological: Matching placebo

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo (VITESS)

The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632...

Enrolling

Non-segmental Vitiligo

Drug: Placebo

Drug: GIA632

Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

The purpose of this extension study is to collect long-term efficacy and safety data on barzolvolimab in adult participants with Chronic Spontaneous...

Invitation-only

Chronic Spontaneous Urticaria

Biological: barzolvolimab

Other: Standard of Care